Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Español Near me My list Help
US Patient GuideUSA
Surprise me
Brand-name prescription medicine

Giapreza

Generic name: Angiotensin II

FDA application holder: La Jolla Pharma

Strengths and generic versions Official label

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

At a glance

2Strengths and forms
1Same medicine, other names
2017FDA approval
0Recalls (FDA reports)

Quick answers

What is Giapreza?
Giapreza is a brand name of Angiotensin II, a prescription medicine. The FDA NDC Directory lists 2 Giapreza products in 2 strengths and forms.
Who makes Giapreza?
La Jolla Pharma holds the FDA application for Giapreza (NDA209360, approved December 21, 2017).
Is there a generic or store brand of Giapreza?
Yes. The FDA NDC Directory lists 1 other product with the same active ingredients, strength and form as a Giapreza product, 1 of them generic. Ask your pharmacist whether one is right for you.
Has Giapreza been recalled?
No recall linked to Giapreza products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Giapreza is

Each Giapreza product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Angiotensin II · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
angiotensin II 0.5 mg/mL
injection (intravenous)		 Giapreza None listed DailyMed
angiotensin II 2.5 mg/mL
injection (intravenous)		 Giapreza 1 product, 1 company DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Angiotensin II →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Giapreza products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA209360La Jolla PharmaDecember 21, 20172

Companies that list Giapreza

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Giapreza products.

Recalls

No recall linked to Giapreza products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers